Real life hexavalent vaccination among children as a practical guide for public health professionals: Four years (from 2016 to 2019) of clinical practice in Sicily, Italy-Reference-Cited by-同舟云学术

Real life hexavalent vaccination among children as a practical guide for public health professionals: Four years (from 2016 to 2019) of clinical practice in Sicily, Italy

Published:2022-11-03 Issue:6 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Costantino Claudio¹^ORCID,Cimino Livia¹,Bonaccorso Nicole¹^ORCID,Conforto Arianna¹,Sciortino Martina¹,Blangiardi Francesco²,Bosco Girolama³,Canzoneri Gaspare⁴,Casuccio Nicolò⁵,Collura Calogero³,Cuccia Mario²⁶,Furnari Roberto²⁶,Genovese Pietro⁴,Gucciardi Giovanni⁴,Randazzo Maria Angela⁵,Taranto Gino Enzo²,Palermo Mario⁷,Vitale Francesco¹

Affiliation:

1. Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Excellence Specialist Medicine, University of Palermo, Palermo, Italy

2. Prevention and Epidemiology Unit, Ragusa Local Health Authority, Ragusa, Italy

3. Prevention and Epidemiology Unit, Agrigento Local Health Authority, Agrigento, Italy

4. Prevention and Epidemiology Unit, Trapani Local Health Authority, Trapani, Italy

5. Prevention and Epidemiology Unit, Palermo Local Health Authority, Palermo, Italy

6. Prevention and Epidemiology Unit, Catania Local Health Authority, Catania, Italy

7. Regional Epidemiological Observatory, Sicilian Health Department, Palermo, Italy

Funder

Investigator-Initiated Studies Program of Merck Sharp & Dohme LLC

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2141998

Reference36 articles.

2. Agenzia Italiana del Farmaco. Vaccini Obbligatori e a Offerta Gratuita e Attiva (Legge 119/2017). [accessed 2022 July 5]. https://www.aifa.gov.it/vaccini-obbligatori-e-a-offerta-gratuita-e-attiva-legge-119-2017#: {}:text=ANTI%2DEPATITE%20B,ENGERIX%20B%20uso&text=HEXYON%20(EPATITE%20B%20%2D%20POLIO%20%2D,%2D%20EPATITE%20A)%20%2D%20uso%20intramuscolare.

3. Italian Ministry of Health. National vaccination plan 2017–2019. [accessed 2022 July 5]. https://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf.

4. DTaP5-HBV-IPV-Hib pediatric hexavalent combination vaccine for use in children from 6 weeks through to 4 years of age

5. Lot-to-lot Consistency, Safety, Tolerability and Immunogenicity of an Investigational Hexavalent Vaccine in US Infants

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016);Human Vaccines & Immunotherapeutics;2024-02-08